Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsFulcrum Therapeutics, Inc. announced positive interim results from the ongoing single- and multiple-ascending dose Phase I trial with FTX-6058 in healthy adult volunteers.
[Fulcrum Therapeutics, Inc.]
Home Newsletters Hematopoiesis News Fulcrum Therapeutics Announces Positive Interim Results from Phase I Healthy Adult Volunteer...
